Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning
Recruiting in Palo Alto (17 mi)
Overseen BySteven G Potkin, M.D.
Age: 18 - 65
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Waitlist Available
Sponsor: University of California, Irvine
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?The purpose of this study is to better understand brain function and psychiatric and neurological illness when taking Invega or Risperdal. The objective is to compare the brain effects of Invega to Risperdal in patients with Schizophrenia. This comparison will be evaluated with PET imaging, fMRI, and neurological ratings and assessments.
Eligibility Criteria
Participant Groups
2Treatment groups
Experimental Treatment
Group I: RisperdalExperimental Treatment1 Intervention
Risperdal 2-8mg per day
Group II: InvegaExperimental Treatment1 Intervention
Invega 6-12mg per day
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
UC IrvineIrvine, CA
Loading ...
Who is running the clinical trial?
University of California, IrvineLead Sponsor
Janssen, LPIndustry Sponsor